Pfizer/BioNTech’s Covid-19 vaccine forecast to capture $30bn in sales

Covid-19
Moderna’s Covid-19 vaccine is expected to receive regulatory decisions from the FDA and EMA in the coming weeks. Credit: Shutterstock.